Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of oral monophasic contraceptive GRT4248 vs ethinylestradiol/desogestrel
2004-003035-31Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ethinyl estradiol + chlormadinone acetate in None (2 arms), sponsored by Grünenthal GmbH. Primary endpoint: Composite safety evaluation. Started Jul 2005; status: completed.
02
Drugs
ethinyl estradiol + chlormadinone acetate
Beyond the preview
Go deeper on 2004-003035-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003035-31.